Habeo Cell Therapy (ECCS-50) - Plus Therap
EPIMSC: Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy (clinicaltrials.gov) - Apr 15, 2020 - P1; N=6; Completed; Sponsor: Mossakowski Medical Research Centre Polish Academy of Sciences; Active, not recruiting ➔ Completed 
Clinical • Trial completion • CNS Disorders • Epilepsy • Immune Modulation • Immunology
http://clinicaltrials.gov/ct2/show/NCT03676569
 
Apr 15, 2020
 
Prev Next